United States
Premiumsupplier
Plecanatide CAS NO.467426-54-6
- Min.Order: 0
- Payment Terms:
- Product Details
Keywords
- L-?Leucine, L-?asparaginyl-?L-?α-?aspartyl-?L-?α-?glutamyl-?L-?cysteinyl-?L-?α-?glutamyl-?L-?leucyl-?L-?cysteinyl-?L-?valyl-?L-?asparaginyl-?L-?valyl-?L-?alanyl-?L-?cysteinyl-?L-?threonylglycyl...
- 105: PN: WO2012037380 SEQID: 105 claimed protein
Quick Details
- ProName: Plecanatide
- CasNo: 467426-54-6
- Molecular Formula: C65H104N18O26S4
- Appearance: Amorphous, White to off-white powder
- Application: Guanylyl cyclase c agonists; gastroint...
- PackAge: 5 mg
- Purity: 95%
- Storage: Store at -20°C
- LimitNum: 0
Superiority
We provide customized and high-quality Plecanatide product for your project.
Details
Plecanatide, also called Trulance, a synthetic analogue of uroguanylin, is a guanylate cyclase-C (GCC) agonist being developed by Synergy Pharmaceuticals for the treatment of gastrointestinal disorders, such as chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C). In January 2017, an oral formulation of plecanatide received its first global approval in the USA for the treatment of adult patients with CIC. Besides, Plecanatide is undergoing phase III investigation in IBS-C. It had also undergone preclinical investigations in inflammatory bowel disease (IBD) and ulcerative colitis; however, development in these indications has been discontinued.
